See How Many Clients You're Missing Each Month

Simply enter your business email & Topline AI Agent will show you.

Bio

Generated by
Topline AI
Pat Masarachia is a seasoned expert in drug discovery, pharmaceutical industry, and biotechnology, with over 30 years of experience in biomedical research, drug development, and clinical development. He holds a Master's degree in Zoology/Animal Biology from the University of North Carolina at Chapel Hill and a Bachelor's degree from the University of Chicago.

Experience

  • Biomedical Research Organization
    • Greater Philadelphia Area
    • Biomedical Information Scientist
      • 2014 - Present
      • Greater Philadelphia Area

      Expert searcher and analyst of the biomedical literature and online databases, both licensed and freely available. Support provided to pharmaceutical research, safety, regulatory compliance, clinical trial, litigation and licensing needs. Scientific and competitive information provided to aid in strategic decision making across entire drug life cycle.

    • Biomedical Information Scientist
      • 2007 - 2014

      Expert searcher and analyst of the biomedical literature and online databases, both licensed and freely available. Responsible for pharmaceutical competitive intelligence updates for specific molecular targets or diseases, covering news, literature, patent, pipeline, clinical trial and grant databases. Proficient in use of indexing, command language searching, and text mining (Linguamatics I2E). Curated and extracted information delivered in actionable reports in support of research, safety, clinical, regulatory, litigation and licensing needs. Subject matter expertise in Osteoporosis, Inflammation, Oncology, Women’s Health, Infectious Diseases, Animal Alternatives and Regulatory.

    • Research Associate
      • Oct 1991 - Aug 2007

      Under the direction of Dr. Gideon Rodan, contributed to the development of the first drug treatment for osteoporosis, alendronate (Fosamax) and a second osteoporosis drug, now in Phase 3 clinical trials, first-in-class Cathepsin K inhibitor, Odanacatib. Contributed to multiple drug development programs for bone disease including DKK-1 antagonists, selective estrogen and androgen receptor modifiers, integrin antagonists and glucocorticoid receptor modifiers. Created in vivo and in vitro assays for drug efficacy, generated data submitted to the FDA, and reported findings in leading scientific journals and at International meetings. Major proficiencies in histology, microscopy and imaging technologies- including light, electron, and confocal microscopy, environmental Scanning electron microscopy, Micro-Computerized Tomography, dual x-ray absorptiometry, immunolabeling, autoradiography, and histomorphometry.

    • Research Associate
      • Sep 1985 - Oct 1991
      • Philadelphia, PA

    • Research Specialist
      • 1979 - 1985
      • Piscataway, NJ

Education

  • The University of Chicago
    Bachelor's Degree, Zoology/Animal Biology
  • University of North Carolina at Chapel Hill
    Master's Degree, Zoology/Animal Biology

Suggested Services

This profile is unclaimed. These are suggested service rates with 0% commision upon successful connection

Industry Focus. “Biotechnology”

Looking to Create a Custom Project?

Need a custom project? We'll create a solution designed specifically for your project.

Get Started

References

Social Profiles

Community

You need to have a working account to view this content. Click here to join now

Similar Profiles